Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan

Arch Iran Med. 2016 Dec;19(12):866-869.

Abstract

Background: Septicemia plays an important role in neonatal morbidity and mortality, especially in developing countries.

Objective: To investigate the bacterial pathogens causing neonatal sepsis and their antibiotic susceptibility profile.

Methodology: A total of 2,685 neonates aged 0-28 days were included in the study. Blood from each neonate was cultured and isolates were identified using standard biochemical tests. Antibiotic sensitivity pattern was analyzed using modified Kirby-Bauer disc diffusion method.

Results: Blood culture positivity was observed in 1,534 (57.1%) samples. Most of the cases (1089 counts - 71%) were of early onset sepsis while 445 (29%) were of late onset sepsis. The incidence of sepsis was higher in males 856 (55.8%) than females 678 (44.2%) with a 1:2 ratio. Similarly, 58.3% of septicemic patients were neonates with low birth weights. Twelve hundred and six (78.6%) isolates were gram negative while 328 (23.4%) were gram positive bacteria. E. coli was the dominant pathogen seen in 811 (52.8%) followed by Staphylococcus aureus 300 (19.5%), Pseudomonas 199 (13%), Klebsiella 102 (6.7%), Proteus 87 (5.7%), Staphylococcus epidermidis 28(1.8%) and Salmonella in 7 (0.5%) samples. All bacterial isolates showed high sensitivity to Imipenem, Enoxacin, Ofloxacin and Ciprofloxacin while low sensitivity was observed for other antibiotics (n = 16). The Proteus species showed high level of multiple resistances to all antibiotics (5.9%).

Conclusion: Imipenem, Enoxacin, Ofloxacin and Ciprofloxacin can be used as an effective antibiotic regimen for treatment of bacterial sepsis in neonates.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Ciprofloxacin / pharmacology
  • Drug Resistance, Bacterial
  • Drug Resistance, Multiple, Bacterial*
  • Enoxacin / pharmacology
  • Escherichia coli / drug effects
  • Escherichia coli / physiology
  • Escherichia coli Infections / microbiology
  • Female
  • Gram-Negative Bacteria / drug effects*
  • Gram-Negative Bacteria / physiology
  • Gram-Negative Bacterial Infections / microbiology*
  • Humans
  • Imipenem / pharmacology
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Klebsiella / drug effects
  • Klebsiella / physiology
  • Klebsiella Infections / microbiology
  • Male
  • Microbial Sensitivity Tests
  • Neonatal Sepsis / microbiology*
  • Ofloxacin / pharmacology
  • Pakistan
  • Proteus / drug effects
  • Proteus / physiology
  • Proteus Infections / microbiology
  • Pseudomonas / drug effects
  • Pseudomonas / physiology
  • Pseudomonas Infections / microbiology
  • Staphylococcal Infections / microbiology*
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / physiology
  • Staphylococcus epidermidis / drug effects*
  • Staphylococcus epidermidis / physiology

Substances

  • Anti-Bacterial Agents
  • Enoxacin
  • Ciprofloxacin
  • Imipenem
  • Ofloxacin